PH31073A - Pharmaceutical composition and process for the preparation thereof. - Google Patents

Pharmaceutical composition and process for the preparation thereof.

Info

Publication number
PH31073A
PH31073A PH45474A PH45474A PH31073A PH 31073 A PH31073 A PH 31073A PH 45474 A PH45474 A PH 45474A PH 45474 A PH45474 A PH 45474A PH 31073 A PH31073 A PH 31073A
Authority
PH
Philippines
Prior art keywords
preparation
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
PH45474A
Other languages
English (en)
Inventor
Magyar Kalman
Gaal Jozsef
Sziraki Istvan
Lengyel Jozsef
Anna Z Szabo
Marmarost Katalin
Hermecz Istvan
Szatmari Istvan
Torok Zoltan
Kormoczy Peter
Original Assignee
Chinoen Gyogyszeres Vegyeszele
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoen Gyogyszeres Vegyeszele filed Critical Chinoen Gyogyszeres Vegyeszele
Publication of PH31073A publication Critical patent/PH31073A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH45474A 1991-12-20 1992-12-18 Pharmaceutical composition and process for the preparation thereof. PH31073A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU914060A HUT63579A (en) 1991-12-20 1991-12-20 Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes

Publications (1)

Publication Number Publication Date
PH31073A true PH31073A (en) 1998-02-05

Family

ID=10966728

Family Applications (1)

Application Number Title Priority Date Filing Date
PH45474A PH31073A (en) 1991-12-20 1992-12-18 Pharmaceutical composition and process for the preparation thereof.

Country Status (27)

Country Link
US (1) US5589513A (fr)
EP (1) EP0617615A1 (fr)
JP (1) JPH07502730A (fr)
KR (1) KR940703655A (fr)
AU (1) AU677170B2 (fr)
BG (1) BG98827A (fr)
BR (1) BR9206950A (fr)
CA (1) CA2125776A1 (fr)
CZ (1) CZ147494A3 (fr)
EC (1) ECSP930933A (fr)
EE (1) EE03015B1 (fr)
FI (1) FI942932A (fr)
HU (2) HUT63579A (fr)
IL (1) IL104150A (fr)
LT (1) LT3119B (fr)
LV (1) LV10386B (fr)
MY (1) MY111055A (fr)
NO (1) NO942303D0 (fr)
NZ (1) NZ246384A (fr)
PH (1) PH31073A (fr)
PL (1) PL172048B1 (fr)
RO (1) RO115785B1 (fr)
RU (1) RU2125448C1 (fr)
SI (1) SI9200404A (fr)
SK (1) SK74494A3 (fr)
WO (1) WO1993012775A1 (fr)
ZA (1) ZA929883B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
DE4432610C1 (de) * 1994-09-13 1996-02-01 Knoll Ag Verfahren zur Herstellung von Selegilin-Hydrochlorid
AU723047B2 (en) 1995-02-10 2000-08-17 University Of Toronto Innovations Foundation, The Deprenyl compounds for treatment of glaucoma
JP4499208B2 (ja) * 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション 新規な光学活性アミノペンタン誘導体
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
HUP9902482A2 (hu) * 1999-07-22 2002-04-29 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. P-fluoro-selegilin alkalmazása neuroprotektív gyógyszerkészítmények előállítására
EP2053033A1 (fr) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Composants à utiliser dans l'imagerie, le diagnostic et/ou le traitement des maladies du système nerveux central ou des tumeurs
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
DE102009045056A1 (de) * 2009-09-28 2011-03-31 Henkel Ag & Co. Kgaa Fleckenvorbehandlungsmittel
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033556A1 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Esters de (17-β)-hydroxy-4-androstène-3-one biodisponibles à l'état solide
WO2016033549A2 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
HU207282B (en) * 1984-05-31 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them
DE3764144D1 (de) * 1986-04-16 1990-09-13 Asta Pharma Ag Synergistische kombination von amantadin und selegilin.
HU207280B (en) * 1986-09-25 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them
HU197510B (en) * 1986-12-19 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
CA2037178A1 (fr) * 1990-02-28 1991-08-29 Albert Walter Brzeczko Composition pharmaceutique a base de deprenyl/l-dopa/carbidopa
GB9011767D0 (en) * 1990-05-25 1990-07-18 Britannia Pharmaceuticals Ltd Pharmaceutical compositions
US5169868A (en) * 1991-03-01 1992-12-08 University Of Saskatchewan Aliphatic propargylamines as specific mao-b inhibitors
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
US5326770A (en) * 1992-07-17 1994-07-05 The Du Pont Merck Pharmaceutical Company Monoamine oxidase-B (MAO-B) inhibitory 5-substituted 2,4-thiazolidinediones useful in treating memory disorders of mammals

Also Published As

Publication number Publication date
FI942932A0 (fi) 1994-06-17
CZ147494A3 (en) 1995-01-18
LV10386A (lv) 1995-02-20
HU914060D0 (en) 1992-03-30
RO115785B1 (ro) 2000-06-30
HUT63579A (en) 1993-09-28
US5589513A (en) 1996-12-31
ECSP930933A (es) 1994-04-20
ZA929883B (en) 1994-05-16
BR9206950A (pt) 1995-11-28
CA2125776A1 (fr) 1993-07-08
EE03015B1 (et) 1997-08-15
IL104150A (en) 1997-11-20
NZ246384A (en) 1996-02-27
AU3265293A (en) 1993-07-28
RU2125448C1 (ru) 1999-01-27
PL172048B1 (pl) 1997-07-31
JPH07502730A (ja) 1995-03-23
LTIP249A (en) 1994-07-15
HU211478A9 (en) 1995-11-28
SK74494A3 (en) 1995-01-12
LT3119B (en) 1994-12-27
SI9200404A (en) 1993-06-30
WO1993012775A1 (fr) 1993-07-08
NO942303D0 (no) 1994-06-17
MY111055A (en) 1999-08-30
FI942932A (fi) 1994-06-17
LV10386B (en) 1995-12-20
KR940703655A (ko) 1994-12-12
BG98827A (en) 1995-06-30
AU677170B2 (en) 1997-04-17
EP0617615A1 (fr) 1994-10-05
NO942303L (fr) 1994-08-17

Similar Documents

Publication Publication Date Title
PH31205A (en) Pharmaceutical composition.
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
PH31073A (en) Pharmaceutical composition and process for the preparation thereof.
IL92425A0 (en) Alpha-d-glucofuranose derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
GB8924286D0 (en) Pharmaceutical composition and process for preparing the same
OA09810A (en) Pharmaceutical composition.
GB9108080D0 (en) Pharmaceutical composition
GB8917687D0 (en) Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
GB9123353D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL107358A0 (en) a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
IL97931A0 (en) Pyridazine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA941088B (en) Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them
GB9310075D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL102116A0 (en) Hetaryloxy-beta-carboline derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same
IL102027A0 (en) Cephem derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
ZA922354B (en) Pharmaceutical composition and process for the preparation thereof
EP0542217A3 (en) Substituted 1,5-pentanediols and processes for the preparation thereof
GB9114006D0 (en) New propionamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL106433A0 (en) Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
IL101566A0 (en) Isoxazolylimidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL116967A (en) Ethyl-6-formyloxy-4-hexenoate and process for the preparation thereof
GB2252497B (en) Pharmaceutical composition
ZA925373B (en) Anti-glaucomatous pharmaceutical compositions and the process for obtaining them.
HRP921428A2 (en) Pharmaceutical preparation and process for the preparation thereof